Evidence map›Paper›PMID 31204694›Full record

ArticleActa crystallographica. Section F, Structural biology communications2019

Changes in the allosteric site of human liver pyruvate kinase upon activator binding include the breakage of an intersubunit cation-π bond.

Jeffrey S McFarlane, Trey A Ronnebaum, Kathleen M Meneely, Annemarie Chilton, Aron W Fenton, Audrey L Lamb

Abstract read
In one paragraph

Article in Acta crystallographica. Section F, Structural biology communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Rheostatic contributions to protein stability can obscure a position's functional role.Protein science : a publication of the Protein Society · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Serendipitous Identification of a Covalent Activator of Liver Pyruvate Kinase.Chembiochem : a European journal of chemical biology · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. An overview of structure, function, and regulation of pyruvate kinases.Protein science : a publication of the Protein Society · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jeffrey S McFarlaneDepartment of Molecular Biosciences, University of Kansas, 1200 Sunnyside, Lawrence, KS 66045, USA.ORCID 0000-0002-0033-4129
Trey A RonnebaumDepartment of Chemistry, University of Kansas, 1200 Sunnyside, Lawrence, KS 66045, USA.ORCID 0000-0002-9214-3564
Kathleen M MeneelyDepartment of Molecular Biosciences, University of Kansas, 1200 Sunnyside, Lawrence, KS 66045, USA.
Annemarie ChiltonDepartment of Molecular Biosciences, University of Kansas, 1200 Sunnyside, Lawrence, KS 66045, USA.
Aron W FentonDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA.ORCID 0000-0001-8214-4785
Audrey L LambDepartment of Molecular Biosciences, University of Kansas, 1200 Sunnyside, Lawrence, KS 66045, USA.ORCID 0000-0002-2352-2130

Funding

X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
TRAINING GRANT IN DYNAMIC ASPECTS OF CHEMICAL BIOLOGYT32GM008545 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI LAMB, AUDREY L · 1994 to 2019
$4.9M
Dissecting Allostery in Pyruvate KinaseR01GM115340 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI FENTON, ARON W · 2016 to 2019
$1.4M
Novel and essential metallophores from multidrug resistant bacterial pathogensR01GM127655 · NIGMS · UNIVERSITY OF TEXAS SAN ANTONIO · PI LAMB, AUDREY L · 2018 to 2020
$910k
American Heart Association PRE33960374National Institutes of Health, National Institute of General Medical Sciences GM008545National Institutes of Health, National Institute of General Medical Sciences GM115340National Institutes of Health, National Institute of General Medical Sciences GM127655National Science Foundation, Division of Chemistry CHE1403293NIGMS NIH HHS P41 GM103393NIGMS NIH HHS R01 GM115340NIGMS NIH HHS R01 GM127655NIGMS NIH HHS T32 GM008545
6 · The paper itself

Abstract

Human liver pyruvate kinase (hLPYK) converts phosphoenolpyruvate to pyruvate in the final step of glycolysis. hLPYK is allosterically activated by fructose-1,6-bisphosphate (Fru-1,6-BP). The allosteric site, as defined by previous structural studies, is located in domain C between the phosphate-binding loop (residues 444-449) and the allosteric loop (residues 527-533). In this study, the X-ray crystal structures of four hLPYK variants were solved to make structural correlations with existing functional data. The variants are D499N, W527H, Δ529/S531G (called GGG here) and S531E. The results revealed a conformational toggle between the open and closed positions of the allosteric loop. In the absence of Fru-1,6-BP the open position is stabilized, in part, by a cation-π bond between Trp527 and Arg538' (from an adjacent monomer). In the S531E variant glutamate binds in place of the 6'-phosphate of Fru-1,6-BP in the allosteric site, leading to partial allosteric activation. Finally, the structure of the D499N mutant does not provide structural evidence for the previously observed allosteric activation of the D499N variant.

Indexed as

MutationAllosteric SiteBinding SitesCationsCrystallography, X-RayFructosediphosphatesHumansLiverModels, MolecularProtein ConformationProtein SubunitsPyruvate KinaseCationsFructosediphosphatesProtein SubunitsPyruvate Kinaseallosterismhuman liver isozymepyruvate kinase

Identifiers

PMID31204694
PMCPMC6572093

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.